Treatment of GHD Associated With CHF
NCT03775993 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 64
Last updated 2019-02-15
Summary
Aim of the current study is to assess the cardiovascular effects of GH replacement therapy in patients with coexisting GHD and CHF
Conditions
- Heart Failure
- Growth Hormone Deficiency
Interventions
- DRUG
-
Human growth hormone
Administration of growth hormone
- OTHER
-
Placebo
Administration of placebo
Sponsors & Collaborators
-
Federico II University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-01
- Primary Completion
- 2022-03-01
- Completion
- 2022-03-01
More Related Trials
-
Growth Hormone in Ischemic Heart Failure
NCT04420481 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of the lOw IGF-1 Syndrome aSsociated With Chronic Heart fAilure: A Randomized, Placebo-Controlled, Double-Blind Study.
NCT01235273 ·Status: SUSPENDED ·Phase: PHASE2
-
Effects of Growth Hormone on Exercise Capacity
NCT00501514 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Effect of Human Recombinant Growth Hormone in Patients With Advanced Heart Failure
NCT00182169 ·Status: COMPLETED ·Phase: PHASE2
-
Growth Hormone and Heart Failure
NCT00190359 ·Status: TERMINATED
-
Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
NCT00187993 ·Status: UNKNOWN
-
Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
NCT00182091 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone and Endothelial Function in Children
NCT00373386 ·Status: COMPLETED ·Phase: PHASE4
-
Growth Hormone Treatment on Phosphocreatine Recovery in Obesity
NCT01421589 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Effects on Growth Hormone Therapy in Adults With Growth Hormone Deficiency
NCT01698944 ·Status: TERMINATED ·Phase: PHASE4
-
Cardiovascular Risk in Growth Hormone Deficient Young Adult Males After Completing Growth Hormone Therapy
NCT00711061 ·Status: COMPLETED
-
Three Month Treatment of Growth Hormone Releasing Hormone (GHRH) in the Elderly
NCT01410799 ·Status: TERMINATED ·Phase: PHASE2
-
Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
NCT00136032 ·Status: COMPLETED ·Phase: NA
-
Growth Hormone's Effect on the Cardiovascular System
NCT00397319 ·Status: TERMINATED
-
The Effect of Growth Hormone Replacement on Liver Fat
NCT00774579 ·Status: COMPLETED
-
Adrenal Function in GHD Children
NCT03203356 ·Status: COMPLETED
-
Dose Study in Growth Hormone Deficient Adults Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083
NCT00715689 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
Effects of Growth Hormone (GH) Deficiency and Growth Hormone Replacement on Serum Fibroblast Growth Factor 21 (FGF21)
NCT02243852 ·Status: WITHDRAWN
-
Effect of 5 Years of GH Replacement on Atherosclerosis
NCT00462475 ·Status: COMPLETED
-
Differential Effects of rhGH vs. rhIGF-1 on Cardiovascular Risk Factors
NCT00684957 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Long Term Effect of Somatropin in Subjects With Intrauterine Growth Retardation
NCT01734447 ·Status: COMPLETED ·Phase: PHASE4
-
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
NCT00493961 ·Status: COMPLETED ·Phase: PHASE1
-
Growth Hormone for the Treatment of Gastroparesis
NCT06803589 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Effect of Somatropin on Left Ventricular Mass in Growth Hormone Deficient Adult Patients
NCT01562834 ·Status: COMPLETED ·Phase: PHASE4